NextBio signs licensing agreement with Merck

NextBio offers the life sciences enterprise secure data access, knowledge discovery and collaboration tools, and enterprise integration capabilities for seamless correlation of internal research data.

Saeid Akhtari, co-founder and CEO of NextBio, said: “We are pleased Merck has chosen NextBio as a drug discovery and development partner. Merck’s adoption of the NextBio solution validates our approach to solving the information bottleneck currently impacting research-driven pharmaceutical and biotechnology companies worldwide. We look forward to further building and extending our relationship with Merck’s researchers over the coming years.”